Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons

Preventive Medicine

Volumn 50, Issue 5-6, 2010, Pages 223-229

  Althoff, Keri N ^a   Anastos, Kathryn ^b   Nelson, Kenrad E ^a   Celentano, David D ^a   Sharp, Gerald B ^c   Greenblatt, Ruth M ^d   French, Audrey L ^e   Diamond, Don J ^f   Holman, Susan ^g   Young, Mary ^h   Gange, Stephen J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Jr Hospital of Cook County   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

^h GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult; Cohort study; Female; Highly active antiretroviral therapy; HIV AIDS; Influenza vaccine; Multi center study; United States; Vaccine coverage

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGE; ARTICLE; ATTITUDE TO HEALTH; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CIGARETTE SMOKING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEALTH BELIEF; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; SEASONAL INFLUENZA; SELF REPORT; UNITED STATES; WOMEN'S HEALTH;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HEALTH CARE SURVEYS; HIV INFECTIONS; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; REGRESSION ANALYSIS; UNITED STATES; VACCINATION; WOMEN;

EID: 77952555271     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2010.03.007     Document Type: Article

References (40)

1. Anema A., Mills E., Montaner J., Bronstein J.S., Cooper C. Efficacy of influenza vaccination in HIv-positive patients: a systematic review and meta-analysis. HIV Med. 2008, 9:31-57.
2. Bacon M.C., von Wyl V., Alden C., Sharp G., Robison E., Hessol N., Gange S., Barranday Y., Holman S., Weber K., Young M.A. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin. Diagn. Lab. Immunol. 2005, 12:1013-1019.
3. Barkan S.E., Melnick S.L., Preston-Martin S., Weber K., Kalish L.A., Miotti P., Young M., Greenblatt R., Sacks H., Feldman J. The Women's Interagency HIV Study. Epidemiology 1998, 9:117-125.
4. Centers for Disease Control and Prevention 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR Recomm. Rep. 1993, 41:1-17.
5. Centers for Disease Control and Prevention.Use of influenza A (H1N1) monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb. Mortal. Wkly Rep. 2009, 58:1-8.
6. Chi R.C., Neuzil K.M. The association of sociodemographic factors and patient attitudes on influenza vaccination rates in older persons. Am. J. Med. Sci. 2004, 327:113-117.
7. Evans K.D., Kline M.W. Prolonged influenza A infection responsive to rimantadine therapy in a human immunodeficiency virus-infected child. Pediatr. Infect. Dis. J. 1995, 14:332-334.
8. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., Bresee J.S., Cox N.J. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2009, 58(RR-8):1-52.
9. Gallagher K.M., Juhasz M., Harris N.S., Teshale E.H. Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002. J. Infect. Dis. 2007, 196:339-346.
10. Golub E.T., Latka M., Hagan H., Havens J.R., Hudson S.M., Kapadia F., Campbell J.V., Garfein R.S., Thomas D.L., Strathdee S.A. Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J. Urban Health 2004, 81:278-290.1.
11. Hornby P.W., Williams A., Burgess M.A., Wang H. Prevalence and determinants of influenza vaccination in Australians aged 40years and over: a national survey. Aust. N. Z. J. Public Health 2005, 29:35-37.
12. Immunization Practices Advisory Committee Recommendations of the immunization practices advisory committee prevention and control of influenza. MMWR Morb. Mortal. Wkly Rep. 1988, 37:361-364.
13. Janz N.K., Becker M.H. The Health Belief Model: a decade later. Health Educ. Q. 1984, 11:1-47.
14. Lau J.T.F., Yang X., Tsui H.Y., Kim J.H. Prevalence of influenza vaccination and associated factors among community-dwelling Hong Kong residents of age 65 or above. Vaccine 2006, 24:5526-5534.
15. Lau J.T.F., Kim J.H., Choi K.C., Tsui H.Y., Yang X. Changes in the prevalence of influenza vaccination and strength of association of factors predicting influenza vaccination over time: results of two population-based surveys. Vaccine 2007, 25:8279-8289.
16. Lin J.C., Nichol K.L. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch. Intern. Med. 2003, 161:441-446.
17. Lu P.J., Euler G.L., Mootre G.T., Ahmed F., Singleton J.A. State-specific influenza vaccination coverage among adults aged ≥18years-United States, 2003-04 and 2005-06 influenza seasons. MMWR Morb. Mortal. Wkly Rep. 2007, 56:953-959.
18. National Health Interview Survey Self-reported influenza vaccination coverage trends 1989-2008 among adults by age group, risk group, race/ethnicity, heath-care worker status, and pregnancy status, United States Available at:, Accessed October 10, 2009. http://www.cdc.gov/flu/professionals/vaccination/pdf/NHIS89_08fluvaxtrendtab.pdf.
19. Neuzil K.M., Reed G.W., Mitchel E.F., Griffin M.R. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999, 281:901-907.
20. Neuzil K.M., Coffey C.S., Mitchel E.F., Griffin M.R. Cardiopulmonary hospitalizations during influenza season in adults and adolescents with advanced HIV infection. J. Acquir. Immune Defic. Syndr. 2003, 34:304-307.
21. Nexøe J., Kragstrup J., Sogaard J. Decision on influenza vaccination among the elderly: a questionnaire study based on the Health Belief Model and the Multidimensional Locus of Control Theory. Scand. J. Prim. Health Care 1999, 17:105-110.
22. Panel on clinical practices for treatment of HIV infection from the US Department of Health and Human Services and Henry J.Kaiser Family Foundation Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents 1998, National Institute of Health, Bethesda, MD.
23. Radwan H.M., Cheeseman S.H., Lai K.K., Ellison R.T. Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season. Clin. Infect. Dis. 2000, 31:604-606.
24. Ranieri R., Veronelli A., Santambrogio C., Pontiroli A.E. Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients. AIDS Res. Hum. Retroviruses 2005, 21:407-409.
25. Rosenstock I.M. The Health Belief Model and preventive health behavior. The Health Belief Model and personal health behavior 1974, 27-59. Charles B. Slack Inc, Thorofare, New Jersey. M.H. Becker (Ed.).
26. Safrin S., Rush J.D., Mills J. Influenza in patients with human immunodeficiency virus infection. Chest 1990, 98:33-37.
27. Schwartz K.L., Neale A.V., Northrup J., Monsur J., Patel D.A., Tobar R., Wortley P.M. Racial similarities in response to standardized offer of influenza vaccination. J. Gen. Intern. Med. 2006, 21:346-351.
28. Skov T., Deddens J., Petersen M.R., Endahl L. Prevalence proportion ratios: estimation and hypothesis testing. Int. J. Epidemiol. 1998, 27:91-95.
29. Sorvillo F.J., Nahlen B.L. Influenza immunization for HIV-infected persons in Los Angeles. Vaccine 1995, 13:377-380.
30. Spiegelman D., Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am. J. Epidemiol. 2005, 162:199-200.
31. Tasker S.A., Treanor J.J., Paxton W.B., Wallace M.R. Efficacy of influenza vaccination in HIV-infected persons: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 1999, 131:430-433.
32. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 249:179-186.
33. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., Fukuda K. Influenza-associated hospitalizations in the United States. JAMA 2004, 292:1333-1340.
34. Thurn J.R., Henry K. Influenza A pneumonitis in a patient infected with the human immunodeficiency virus (HIV). Chest 1989, 95:807-810.
35. US Department of Health and Human Services Healthy People 2010: Understanding and Improving Health 2008, U.S. Government Printing Office, Washington DC. 2nd ed.
36. Wortley P.M., Farizo K.M. Pneumococcal and influenza vaccination levels among HIV-infected adolescents and adults receiving medical care in the United States. AIDS 1994, 8:941-944.
37. Yamanaka H., Teruya K., Tanaka M., Kikuchi Y., Takahashi T., Kimura S., Oka S. Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients. J. Acquir. Immune Defic. Syndr. 2005, 39:167-173.
38. Zeger S.L., Liang K.Y., Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988, 44:1049-1060.
39. Zimmerman R.K., Raymund M., Janosky J.E., Nowalk M.P., Fine M.J. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 2003, 21:1486-1491.
40. Zocchetti C., Consonni D., Bertazzi P.A. Relationship between prevalence rate ratios and odds ratios in cross-sectional studies. Int. J. Epidemiol. 1997, 26:220-223.